Back
Day Range
$100.00
$1,001.00
52-Week Range
$96.50
$1,001.00
Volume
100
50D / 200D Avg
$103.96
/
$108.24
Prev Close
$100.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 26.0 | 0.4 |
| P/B | 3.9 | 2.9 |
| ROE % | 16.0 | 3.8 |
| Net Margin % | 12.7 | 3.9 |
| Rev Growth 5Y % | 4.8 | 10.0 |
| D/E | 0.5 | 0.2 |
Key Takeaways
Revenue grew 4.77% annually over 5 years — modest growth
ROE of 16.00% — decent returns on equity
Generating 9.98M in free cash flow
Growth
Revenue Growth (5Y)
4.77%
Revenue (1Y)2.62%
Earnings (1Y)5.42%
FCF Growth (3Y)-62.65%
Quality
Return on Equity
16.00%
ROIC9.26%
Net Margin12.70%
Op. Margin15.84%
Safety
Debt / Equity
0.51
Current Ratio2.00
Interest Coverage29.47
Valuation
P/E Ratio
25.96
P/B Ratio3.88
EV/EBITDA23.06
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.62% | Revenue Growth (3Y) | 2.22% |
| Earnings Growth (1Y) | 5.42% | Earnings Growth (3Y) | 22.32% |
| Revenue Growth (5Y) | 4.77% | Earnings Growth (5Y) | 15.26% |
| Profitability | |||
| Revenue (TTM) | 1.33B | Net Income (TTM) | 168.74M |
| ROE | 16.00% | ROA | 7.83% |
| Gross Margin | 26.54% | Operating Margin | 15.84% |
| Net Margin | 12.70% | Free Cash Flow (TTM) | 9.98M |
| ROIC | 9.26% | FCF Growth (3Y) | -62.65% |
| Safety | |||
| Debt / Equity | 0.51 | Current Ratio | 2.00 |
| Interest Coverage | 29.47 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 25.96 | P/B Ratio | 3.88 |
| P/S Ratio | 3.30 | PEG Ratio | 5.70 |
| EV/EBITDA | 23.06 | Dividend Yield | 0.00% |
| Market Cap | 4.38B | Enterprise Value | 4.85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.33B | 1.29B | 1.27B | 1.23B | 1.10B |
| Net Income | 168.74M | 160.06M | 112.77M | 156.49M | 95.60M |
| EPS (Diluted) | 3.85 | 3.69 | 2.62 | 3.63 | 2.20 |
| Gross Profit | 352.56M | 329.06M | 320.41M | 318.89M | 239.57M |
| Operating Income | 210.43M | 199.26M | 172.07M | 230.78M | 131.95M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.15B | 1.93B | 1.86B | 1.79B | 1.67B |
| Total Liabilities | 1.03B | 953.81M | 1.02B | 1.00B | 980.94M |
| Shareholders' Equity | 1.13B | 980.19M | 838.24M | 790.93M | 688.22M |
| Total Debt | 575.48M | 490.10M | 525.00M | 590.00M | 560.00M |
| Cash & Equivalents | 103.13M | 38.76M | 56.36M | 91.48M | 72.62M |
| Current Assets | 1.05B | 939.38M | 983.16M | 944.89M | 826.17M |
| Current Liabilities | 524.98M | 306.60M | 397.80M | 317.59M | 270.79M |